Cargando…

TET2 and DNMT3A mutations and exceptional response to 4′-thio-2′-deoxycytidine in human solid tumor models

BACKGROUND: Challenges remain on the selection of patients who potentially respond to a class of drugs that target epigenetics for cancer treatment. This study aims to investigate TET2/DNMT3A mutations and antitumor activity of a novel epigenetic agent in multiple human cancer cell lines and animal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Sherry X., Hollingshead, Melinda, Rubinstein, Larry, Nguyen, Dat, Larenjeira, Angelo B. A., Kinders, Robert J., Difilippantonio, Michael, Doroshow, James H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8157655/ https://www.ncbi.nlm.nih.gov/pubmed/34039392 http://dx.doi.org/10.1186/s13045-021-01091-5

Ejemplares similares

DNA damage, demethylation and anticancer activity of DNA methyltransferase (DNMT) inhibitors
por: Laranjeira, Angelo B. A., et al.
Publicado: (2023)

Intravenous 5-fluoro-2′-deoxycytidine administered with tetrahydrouridine increases the proportion of p16-expressing circulating tumor cells in patients with advanced solid tumors
por: Coyne, Geraldine O.’Sullivan, et al.
Publicado: (2020)

5-Aza-2′-deoxycytidine-induced genome rearrangements are mediated by DNMT1
por: Maslov, Alexander Y., et al.
Publicado: (2012)

DNMT3a and TET2 in adipocyte insulin sensitivity
por: Villivalam, Sneha Damal, et al.
Publicado: (2018)

AID downregulation is a novel function of the DNMT inhibitor 5-aza-deoxycytidine
por: Tsai, Chiou-Tsun, et al.
Publicado: (2013)

PBRM1 Deficiency Sensitizes Renal Cancer Cells to DNMT Inhibitor 5-Fluoro-2’-Deoxycytidine
por: Gu, Di, et al.
Publicado: (2022)

DNMT3A and TET2 in the Pre-Leukemic Phase of Hematopoietic Disorders
por: Sato, Hanae, et al.
Publicado: (2016)

Targeting of 5-aza-2′-deoxycytidine residues by chromatin-associated DNMT1 induces proteasomal degradation of the free enzyme
por: Patel, Katan, et al.
Publicado: (2010)

Synergistic Interactions between the Hypomethylating Agent Thio-Deoxycytidine and Venetoclax in Myelodysplastic Syndrome Cells
por: Hu, Xiaoyan, et al.
Publicado: (2023)

Development and Validation of an Immunoassay for Quantification of Topoisomerase I in Solid Tumor Tissues
por: Pfister, Thomas D., et al.
Publicado: (2012)

Divergent Effects of Dnmt3a and Tet2 Mutations on Hematopoietic Progenitor Cell Fitness
por: Ostrander, Elizabeth L., et al.
Publicado: (2020)

Regulation of CpG methylation by Dnmt and Tet in pluripotent stem cells
por: HORII, Takuro, et al.
Publicado: (2016)

Development of a quantitative pharmacodynamic assay for apoptosis in fixed tumor tissue and its application in distinguishing cytotoxic drug—induced DNA double strand breaks from DNA double strand breaks associated with apoptosis
por: Dull, Angie B., et al.
Publicado: (2018)

Modeling Pharmacodynamic Response to the Poly(ADP-Ribose) Polymerase Inhibitor ABT-888 in Human Peripheral Blood Mononuclear Cells
por: Ji, Jiuping, et al.
Publicado: (2011)

Combined heterozygosity of FLT3(ITD), TET2, and DNMT3A results in aggressive leukemia
por: Ramdas, Baskar, et al.
Publicado: (2022)

Notch1 phenotype and clinical stage progression in non-small cell lung cancer
por: Nguyen, Dat, et al.
Publicado: (2015)

Aza-deoxycytidine induces apoptosis or differentiation via DNMT3B and targets embryonal carcinoma cells but not their differentiated derivatives
por: Wongtrakoongate, P, et al.
Publicado: (2014)

Genome-wide methylation data from R1 (wild-type) and the transgenic Dnmt1(Tet/Tet) mouse embryonic stem cells overexpressing DNA methyltransferase 1 (DNMT1)
por: Saxena, Sonal, et al.
Publicado: (2020)

The epigenetic impact of suberohydroxamic acid and 5-Aza-2′-deoxycytidine on DNMT3B expression in myeloma cell lines differing in IL-6 expression
por: Smesny Trtkova, Katerina, et al.
Publicado: (2022)

Clinical Implication of DNMT3A and TET2 Genes Mutations in Cytogenetically Normal Acute Myeloid Leukemia
por: Aref, Salah, et al.
Publicado: (2022)

Intragenomic Decarboxylation of 5‐Carboxy‐2′‐deoxycytidine
por: Kamińska, Ewelina, et al.
Publicado: (2021)

TETs compete with DNMT3 activity in pluripotent cells at thousands of methylated somatic enhancers
por: Charlton, Jocelyn, et al.
Publicado: (2020)

Epigenetic alterations associated with dexamethasone sodium phosphate through DNMT and TET in RPE cells
por: Liu, Wenjie, et al.
Publicado: (2021)

DNMT3A and TET2 compete and cooperate to repress lineage-specific transcription factors in hematopoietic stem cells
por: Zhang, Xiaotian, et al.
Publicado: (2016)

P1001: DNMT3A/TET2/ASXL1 MUTATIONS DETERMINE THROMBOTIC RISK IN POLYCYTHAEMIA VERA
por: Segura Diaz, A., et al.
Publicado: (2022)

Different Binding Properties and Function of CXXC Zinc Finger Domains in Dnmt1 and Tet1
por: Frauer, Carina, et al.
Publicado: (2011)

Thrombotic Risk Detection in Patients with Polycythemia Vera: The Predictive Role of DNMT3A/TET2/ASXL1 Mutations
por: Segura-Díaz, Adrián, et al.
Publicado: (2020)

Clonal hematopoiesis driven by DNMT3A and TET2 mutations: role in monocyte and macrophage biology and atherosclerotic cardiovascular disease
por: Cobo, Isidoro, et al.
Publicado: (2022)

Endogenous epitope-tagging of Tet1, Tet2 and Tet3 identifies TET2 as a naïve pluripotency marker
por: Pantier, Raphaël, et al.
Publicado: (2019)

ZFP281 coordinates DNMT3 and TET1 for transcriptional and epigenetic control in pluripotent state transitions
por: Huang, Xin, et al.
Publicado: (2023)

Single Nucleotide Polymorphism Array Lesions, TET2, DNMT3A, ASXL1 and CBL Mutations Are Present in Systemic Mastocytosis
por: Traina, Fabiola, et al.
Publicado: (2012)

PU.1 target genes undergo Tet2-coupled demethylation and DNMT3b-mediated methylation in monocyte-to-osteoclast differentiation
por: de la Rica, Lorenzo, et al.
Publicado: (2013)

p53 promotes the expansion of regulatory T cells via DNMT3a- and TET2- mediated Foxp3 expression in sepsis
por: Zhang, Hui, et al.
Publicado: (2023)

DNMT3A and TET1 cooperate to regulate promoter epigenetic landscapes in mouse embryonic stem cells
por: Gu, Tianpeng, et al.
Publicado: (2018)

A genome-scale map of DNA methylation turnover identifies site-specific dependencies of DNMT and TET activity
por: Ginno, Paul Adrian, et al.
Publicado: (2020)

5-Aza-2′-deoxycytidine stress response and apoptosis in prostate cancer
por: Patra, Aditi, et al.
Publicado: (2011)

Detection of Oxidation Products of 5-Methyl-2′-Deoxycytidine in Arabidopsis DNA
por: Liu, Shuo, et al.
Publicado: (2013)

Epigenetic regulation of the circadian clock: role of 5-aza-2′-deoxycytidine
por: Tomita, Tatsunosuke, et al.
Publicado: (2017)

Effect of Sulforaphane and 5-Aza-2’-Deoxycytidine on Melanoma Cell Growth
por: Chiang, Tung-chin, et al.
Publicado: (2019)

A study of 7-deaza-2′-deoxyguanosine–2′-deoxycytidine base pairing in DNA
por: Ganguly, Manjori, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_2v0o9pl9p5fca9l8r1rkgvh9fm